Chen Michael Cunyuan sold SPTX

May 4, 2026 · Form 4 insider transaction

Chen Michael Cunyuan sold 10,526 shares of Seaport Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
10,526
Price
$0.00
Total value
N/A
RoleOfficer
SecuritySeries B Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 4, 2026
Filing dateMay 4, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date.

View the original Form 4 on SEC EDGAR